SLC45A3 抗体 (AA 351-450) (Biotin)
-
- 抗原 See all SLC45A3 products
- SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))
-
抗原表位
- AA 351-450
-
适用
- 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This SLC45A3 antibody is conjugated to Biotin
-
应用范围
- Western Blotting (WB), ELISA
- 交叉反应
- 大鼠
- 预测反应
- Human,Mouse,Dog,Cow,Sheep,Pig,Arabidopsis Thaliana
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human PCANAP2
- 亚型
- IgG
-
-
- 应用备注
- WB 1:300-5000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C for 12 months.
- 有效期
- 12 months
-
- 抗原
- SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))
- 别名
- PCANAP2 (SLC45A3 产品)
- 背景
-
Synonyms: IPCA 2, IPCA 8, IPCA6, PCANAP2, PCANAP6, PCANAP8, Prostate cancer associated gene 2, Prostate cancer associated gene 6, Prostate cancer associated gene 8, Prostate cancer associated protein 2, Prostate cancer associated protein 6, Prostate cancer associated protein 8, Prostate cancer-associated protein 6, Prostein, PRST, S45A3_HUMAN, Slc45a3, Solute carrier family 45 member 3.
Background: PSA, prostate specific antigen, is the classic indicator for transformed pro-state tissue, however, in addition to being upregulated in prostate cancer, PSA is also upregulated in non-malignant conditions, such as benign prostatic hyperplasia. Prostein, also designated Prostate cancer-associated protein 6, is a prostate-specific, 553 amino acid transmembrane protein that is upregulated by androgens. It is considered a marker for prostate cells since it is expressed in all prostatic glandular cells as well as in normal and cancerous prostate tissues. Since it is able to elicit a tumor-directed cytotoxic T cell response, Prostein may be used as a target for the development of PSA- and T cell-based therapeutic strategies for prostate cancer.
- 基因ID
- 85414
-